Skip to main content

Table 1 Patient and tumor characteristics of 38 breast cancers and 37 patients

From: Preliminary toxicity results using partial breast 3D-CRT with once daily hypo-fractionation and deep inspiratory breath hold

Characteristics

n

%

Female

38

100

Age (median, years)

 

62 years (range: 52–79)

Laterality

 Right

18

47

 Left

20

53

Menopausal status

 Pre-menopausal

0

 

 Post-menopausal

37

97

 Unknown

1

3

Surgical margin

 Negative

37

97

 Positive

1

3

Surgery, breast

 Lumpectomy

38

100

 Mastectomy

0

 

Surgery, Axilla

 None

11

29

 SLNBx

27

71

 ALND

0

 

Histology

 DCIS

12

32

 Invasive Ductal Carcinoma

21

55

 Invasive Lobular Carcinoma

5

13

T stage

 Tis

9

24

 T1a

5

13

 T1b

9

24

 T1c

12

32

 T2

3

8

N stage

 N0

38

100

M stage

 M0

38

100

LVSI

 No

11

29

 Yes

0

 

 Not reported

27

71

Grade

 1

8

21

 2

21

55

 3

9

24

ER+

32

84

 Unknown

0

 

PR+

20

53

 Unknown

8

21

HER2+

2

5

 Unknown

12

32

Multi-focal

14

37

Hormonal therapy

28

74

Chemotherapy

5

13

  1. Abbreviations: SLNBx sentinel lymph node biopsy, ALND axillary lymph node dissection, DCIS ductal carcinoma in situ, LVSI lympho-vascular space invasion, ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2